glp- 1 oral solution Guide to GLP-1 Medications for Weight Loss and Diabetes An Oral GLP-1 Receptor Agonist

de Levia, Brugus, de Leiva-Prez)

They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain

While telehealth expands access, it should not replace thorough monitoring

Constipation : Conversely, others may face constipation due to slowed gut movement